Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-11 Sale |
2022-11-15 5:01 pm |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
56,786 | $16.38 | $929,871 | 342,500 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-16 5:01 pm |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
18,214 | $14.49 | $263,921 | 399,286 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Exercise |
2025-02-19 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
16,667 | $0 | 723,437 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
5,965 | $0 | 723,437 (Direct) |
View |
| 2024-12-27 Exercise |
2024-12-31 4:30 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
6,667 | $0 | 729,402 (Direct) |
View |
| 2024-12-27 Tax Withholding |
2024-12-31 4:30 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
2,345 | $0 | 729,402 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
6,855 | $0 | 731,747 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-11 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
2,415 | $0 | 731,747 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 5:01 pm |
N/A 2024-11-21 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
154,362 | $0 | 1,400,433 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
16,667 | $0 | 579,800 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
6,025 | $0 | 579,800 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
6,666 | $0 | 585,825 (Direct) |
View |
| 2023-12-27 Tax Withholding |
2023-12-29 5:00 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
2,409 | $0 | 585,825 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 5:00 pm |
N/A 2030-12-08 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
163,758 | $0 | 1,134,619 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 5:01 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
16,666 | $0 | 424,476 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 5:01 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
6,024 | $0 | 424,476 (Direct) |
View |
| 2022-12-27 Option Award |
2022-12-29 4:49 pm |
N/A 2029-12-27 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
88,000 | $0 | 841,000 (Direct) |
View |
| 2022-11-11 Exercise |
2022-11-15 5:01 pm |
2022-07-06 2028-07-06 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
56,786 | $0 | 342,500 (Direct) |
View |
| 2022-11-11 Exercise |
2022-11-15 5:01 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
56,786 | $5.49 | 342,500 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 5:01 pm |
2022-07-06 2028-07-06 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
18,214 | $0 | 399,286 (Direct) |
View |
| 2022-09-15 Exercise |
2022-09-16 5:01 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
18,214 | $5.49 | 399,286 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-16 5:05 pm |
N/A N/A |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Strategy Officer |
50,000 | $0 | 417,500 (Direct) |
View |
| 2021-12-28 Option Award |
2021-12-30 4:50 pm |
N/A 2028-12-28 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Product Devel. Officer |
67,500 | $0 | 367,500 (Direct) |
View |
Ownership |
2021-07-13 4:44 pm |
N/A 2028-07-06 |
CATALYST PHARMACEUTICALS INC. | CPRX | Sundaram Preethi Chief Product Devel. Officer |
0 | $0 | 300,000 (Direct) |
View |